Neale Cohen is currently the head of Clinical Services at the Baker Heart and Diabetes Institute in Melbourne. He is an endocrinologist in clinical practice for over 30 years at the Baker Institute. In his current position he is responsible for the management of one of the largest diabetes outpatient services in Victoria, now recognized as an IDF centre of excellence. He is an Adjunct Associate Professor at University of Queensland and Monash University. A/Prof Cohen is head of the Diabetes Clinical Research laboratory at The Baker Institute and has wide ranging clinical research interests and publications including technology and diabetes, indigenous diabetes, and novel models of care. He is currently Co-Lead of the Diabetes Program at The Baker Institute leading 6 research labs.

Dr Jane Holmes-Walker was employed as a staff specialist in the Dept of Endocrinology, Westmead Hospital in 1998 after completing her training at Westmead Hospital and Middlesex Hospital and University College Hospitals in London. She completed a PhD in the Faculty of Medicine, University of Sydney on 'The A3243G mitochondrial DNA mutation: Contribution to pathogenesis of diabetes mellitus and its complications' awarded in 1999. She has developed a number of new clinical services at Westmead including the Diabetes Transition Support Program for young people with diabetes, The NeuroEndocrine Tumour Service, the Metabolic Bone Disease service and was successful in obtaining long term funding for the Adult Genetic Metabolic Disease service. She is on the ACI committee for Transition which seeks to improve the management of young people with chronic disease and has been involved in the writing of National Guidelines for management of Type I diabetes and Management of Cystic Fibrosis related Diabetes. She has >20 publications in peer reviewed journals.

Chun-Kwan O is a PhD student in Medical Sciences in the Chinese University of Hong Kong. He is working on precision and structured care of individuals with young-onset diabetes.

Takahiro Tosaki, M.D., Ph.D., is the Director of Tosaki Clinic for Diabetes and Endocrinology. He serves as Secretary General of the Aichi Council for CDE and a member of the Japan Diabetes Society. He is dedicated to advancing diabetes care through clinical excellence and medical staff education.

Dr Harshal Deshmukh is an endocrinologist and clinician-scientist based in regional Queensland, Australia. His research focuses on diabetes technology, insulin efficiency, and improving outcomes in underserved populations. He has published extensively and leads innovative clinical and implementation research to advance equitable, evidence-based diabetes and metabolic care.

Dr Aniket Nadkarni is an intensive care specialist at the Austin Hospital, Melbourne, and is a PhD candidate at Adelaide University, with a thesis titled "Mitigating the short and long term complications of stress-induced hyperglycaemia". His research interests including glycaemic control in the critically ill, neurocritical care, and iatrogenic anaemia.

Dr Neisha D’Silva is a Senior Staff Endocrinologist at Mater Hospital Brisbane. She was lead author of the National Guidelines for the Assessment and Management of Disordered Eating/Eating Disorders (ED) in Type 1 Diabetes, endorsed by ADS, ANZSPED and ACBRD. Her clinical and research work focuses on diabetes-specific ED prevention.

Isabella Magee is a Diabetes Australia Ambassador, International Diabetes Federation (IDF) Young Leader, communications specialist, and Nutrition and Dietetics student. Living with type 1 diabetes for more than 17 years, she combines her lived experience with expertise in health communication to advance diabetes awareness, education, and advocacy. As an IDF Young Leader, she leads 'Sweet Talk: Speak to Be Heard', a global initiative that empowers the diabetes community to advocate for meaningful change in their everyday lives. Isabella also co-hosts the Diabetes Australia podcast 'Life on the Level' and is passionate about amplifying lived experience to improve diabetes care, outcomes, and equity worldwide.

A/Prof Glenn Ward is Deputy Director of Endocrinology, Head of Diabetes, and Clinical Consultant in Biochemistry at St Vincent’s Hospital Melbourne, and an Endocrinologist in the Australian Islet Transplant Program. Past roles include Medical Director of Pathology, President of the Australian Diabetes Society, and Board Member of Diabetes Australia National

Aditya Nachanekar is a final-year PhD student affiliated with the Western Sydney University, diabetes and islet biology group. His work focuses on investigating the role of extracellular vesicles obtained from human islet-derived progenitor cells in T1D therapy.